{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:14:51Z","timestamp":1791029691461,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1976,5,1]],"date-time":"1976-05-01T00:00:00Z","timestamp":199756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canad. Anaesth. Soc. J."],"published-print":{"date-parts":[[1976,5]]},"DOI":"10.1007\/bf03005702","type":"journal-article","created":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T03:35:02Z","timestamp":1228880102000},"page":"263-284","source":"Crossref","is-referenced-by-count":53,"title":["Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations"],"prefix":"10.1007","volume":"23","author":[{"given":"Pearl L.","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Endrenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis H. -F.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley A.","family":"Britt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Kadijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03005702_CR1","first-page":"207","volume":"11","author":"Y. Fujie","year":"1960","unstructured":"Fujie, Y. Distribution of creatine phosphokinase among mammalian tissues. Seitai no Kagaku11: 207(1960).","journal-title":"Seitai no Kagaku"},{"key":"BF03005702_CR2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1042\/bj0610116","volume":"61","author":"I.T. Oliver","year":"1955","unstructured":"Oliver, I.T. A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem. J.61: 116 (1955).","journal-title":"Biochem. J."},{"key":"BF03005702_CR3","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1016\/S0021-9258(18)69649-8","volume":"234","author":"M.L. Tanzer","year":"1959","unstructured":"Tanzer, M.L. &Gilvarg, C. Creatine and creatine kinase measurement. J. Biol. Chem.234: 3201 (1959).","journal-title":"J. Biol. Chem."},{"key":"BF03005702_CR4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0019-2791(67)90132-2","volume":"6","author":"J.A. Bulcke","year":"1969","unstructured":"Bulcke, J.A. &Sherwin, A.L. Organ specificity of creatine phosphokinase muscle isoenzyme. Immunochemistry6: 681 (1969).","journal-title":"Immunochemistry"},{"key":"BF03005702_CR5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0021-9258(18)63242-9","volume":"245","author":"R.J. Baskin","year":"1970","unstructured":"Baskin, R.J. &Deamer, D.W. A membrane-bound creatine phosphokinase in fragmented sarcoplasmic reticulum. J. Biol. Chem.245: 1345 (1970).","journal-title":"J. Biol. Chem."},{"key":"BF03005702_CR6","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1016\/S0021-9258(19)45939-5","volume":"246","author":"L.B. Oscai","year":"1971","unstructured":"Oscai, L.B. &Holloszy, J.O. Biochemical adaptations in muscle. II Response of mitochondrial adenosine triphosphatase, creatine phosphokinase and adenylate kinase activities in skeletal muscle to exercise. J. Biol. Chem.246: 6968 (1971).","journal-title":"J. Biol. Chem."},{"key":"BF03005702_CR7","first-page":"264","volume":"271","author":"K. Lohmann","year":"1934","unstructured":"Lohmann, K. Uber die enzymatische aufspaltung der kreatinphosphosaure; zugleich ein beitrag zum chemismus der muskelkontraktion. Biochem. Z.,271: 264 (1934).","journal-title":"Biochem. Z."},{"key":"BF03005702_CR8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF03026208","volume":"20","author":"B.A. Britt","year":"1973","unstructured":"Britt, B.A., Kalow, W., Gordon, A., Humphrey, J.G., &Rewcastle, N.B. Malignant hyperthermia: an investigation of five patients. Canad. Anaesth. Soc. J.20: 431 (1973).","journal-title":"Canad. Anaesth. Soc. J."},{"key":"BF03005702_CR9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0031-6997(25)07050-4","volume":"17","author":"A. Sandow","year":"1965","unstructured":"Sandow, A. Excitation-contraction coupling in skeletal muscle. Pharmac. Rev.17: 265 (1965).","journal-title":"Pharmac. Rev."},{"key":"BF03005702_CR10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.ph.32.030170.000511","volume":"32","author":"A. Sandow","year":"1970","unstructured":"Sandow, A. Skeletal muscle. Ann. Rev. Physiol.32: 87 (1970).","journal-title":"Ann. Rev. Physiol."},{"key":"BF03005702_CR11","first-page":"1","volume":"22","author":"S.V. Perry","year":"1968","unstructured":"Perry, S.V. The role of myosin in muscular contraction. Society for Experimental Biology, Aspects of Cell Motility,22: 1 (1968).","journal-title":"Society for Experimental Biology, Aspects of Cell Motility"},{"key":"BF03005702_CR12","first-page":"300","volume":"20","author":"A. Weber","year":"1961","unstructured":"Weber, A. &Winicur, S. Dependence of superprecipitation of actomyosin on the concentration of ionized calcium. Fed. Proc.20: 300 (1961).","journal-title":"Fed. Proc."},{"key":"BF03005702_CR13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0006-291X(61)90146-2","volume":"6","author":"A. Weder","year":"1961","unstructured":"Weder, A. &Herz, R. Requirement for calcium in the synaeresis of myofibrils. Biochem. Biophys. Res. Comm.6: 364 (1961).","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"BF03005702_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0079-6107(68)90023-0","volume":"18","author":"S. Ebashi","year":"1968","unstructured":"Ebashi, S. &Endo, M. Calcium ion and muscle contraction. Progr. Biophys. Mol. Biol.18: 123 (1968).","journal-title":"Progr. Biophys. Mol. Biol."},{"key":"BF03005702_CR15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0006-291X(70)90724-2","volume":"28","author":"M.H. Han","year":"1970","unstructured":"Han, M.H. &Benson, E.S. Conformational changes in troponin induced by Ca++. Biochem. Biophys. Res. Comm.28: 378 (1970).","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"BF03005702_CR16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/oxfordjournals.jbchem.a128955","volume":"64","author":"T. Wakabayashi","year":"1968","unstructured":"Wakabayashi, T. &Ebashi, S. Reversible change in physical state of troponin induced by calcium ion. J. Biochem.64: 731 (1968).","journal-title":"J. Biochem."},{"key":"BF03005702_CR17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1085\/jgp.48.6.997","volume":"48","author":"S. Winecrad","year":"1965","unstructured":"Winecrad, S. The location of muscle calcium with respect to the myofibrils. J. Gen. Physiol.48: 997 (1965).","journal-title":"J. Gen. Physiol."},{"key":"BF03005702_CR18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0021-9258(19)81727-1","volume":"243","author":"B. Yasui","year":"1968","unstructured":"Yasui, B., Fuchs, F., &Briggs, F.N. The role of the sulfhydryl groups of tropomyosin and troponin in the calcium control of actomyosin contractility. J. Biol. Chem.243: 735 (1968).","journal-title":"J. Biol. Chem."},{"key":"BF03005702_CR19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1152\/jappl.1962.17.6.943","volume":"17","author":"W.M. Fowler","year":"1962","unstructured":"Fowler, W.M., Chowdhury, S.R., Pearson, CM., Gardner, G., &Bratton, R. Changes in serum enzyme levels after exercise in trained and untrained subjects. J. Appl. Physiol.17: 943(1962).","journal-title":"J. Appl. Physiol."},{"key":"BF03005702_CR20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0009-8981(66)90230-0","volume":"13","author":"P.D. Griffiths","year":"1966","unstructured":"Griffiths, P.D. Serum levels of ATP, creatine phosphotransferase and creatine kinase. The normal range and effect of muscular activity. Clin. Chim. Acta13: 413 (1966).","journal-title":"Clin. Chim. Acta"},{"key":"BF03005702_CR21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.5694\/j.1326-5377.1972.tb47015.x","volume":"1","author":"J.O. King","year":"1972","unstructured":"King, J.O. &Zapf, P. A review of the value of creatine phosphokinase estimations in clinical medicine. Med. J. Aust.1: 699 (1972).","journal-title":"Med. J. Aust."},{"key":"BF03005702_CR22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.7326\/0003-4819-61-6-1015","volume":"61","author":"J.W. Hess","year":"1964","unstructured":"Hess, J.W., MacDonald, R.P., Frederick, R.J., Jones, R.N., Neely, J., &Gross, D. Serum creatine phosphokinase (CPK) activity in disorders of heart and skeletal muscle. Ann. Int. Med.61: 1015(1964).","journal-title":"Ann. Int. Med."},{"key":"BF03005702_CR23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0009-8981(66)90209-9","volume":"13","author":"K.J. Veen Van der","year":"1966","unstructured":"Van der Veen, K.J. &Willebrands, A.F. Isoenzymes of creatine phosphokinase in tissue extracts and in normal and pathological sera. Clin. Chim. Acta13: 312 (1966).","journal-title":"Clin. Chim. Acta"},{"key":"BF03005702_CR24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/ajcp\/43.3.207","volume":"43","author":"N.C. Kar","year":"1965","unstructured":"Kar, N.C. &Pearson, CM. Creatine phosphokinase isoenzymes in muscle in human myopathies. Am. J. Clin. Pathol.43: 207 (1965).","journal-title":"Am. J. Clin. Pathol."},{"key":"BF03005702_CR25","first-page":"269","volume":"33","author":"A. McCrimmon","year":"1967","unstructured":"McCrimmon, A. &Lewin, E. Serum creatine phosphokinase: a useful tool in muscle disease. Am. J. Med. Tech.33: 269 (1967).","journal-title":"Am. J. Med. Tech."},{"key":"BF03005702_CR26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0022-510X(71)90084-0","volume":"14","author":"G. Karpati","year":"1971","unstructured":"Karpati, G. &Sherwin, A.L. Immunohistochemical study of creatine phosphokinase in pathological human muscle. J. Neurol. Sci.14: 153 (1971).","journal-title":"J. Neurol. Sci."},{"key":"BF03005702_CR27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0009-8981(71)90310-X","volume":"35","author":"W.H.S. Thomson","year":"1971","unstructured":"Thomson, W.H.S. Serum enzyme studies in inherited disease of skeletal muscle. Clin. Chim. Acta35:183 (1971).","journal-title":"Clin. Chim. Acta"},{"key":"BF03005702_CR28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jnnp.27.2.96","volume":"27","author":"J.M.S. Pearce","year":"1964","unstructured":"Pearce, J.M.S., Pennington, R.J., &Walton, J.N. Serum enzyme studies in muscle disease. Part II. Serum creatine kinase activity in muscular dystrophy and other myopathic and neuropathic disorders. J. Neurol. Neurosurg. Psychiat.27: 96 (1964).","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"BF03005702_CR29","first-page":"53","volume":"69","author":"E.R. Williams","year":"1967","unstructured":"Williams, E.R. &Bruford, A. Creatine phosphokinase in motor neurone disease. Clin. Chim. Acta69: 53 (1967).","journal-title":"Clin. Chim. Acta"},{"key":"BF03005702_CR30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0009-8981(69)90352-0","volume":"23","author":"A. Cao","year":"1969","unstructured":"Cao, A., DeVirgiliis, S., Lippi, C, &Trabalza, N. Creatine kinase isoenzymes in serum of children with neurological disorders. Clin. Chim. Acta23: 475 (1969).","journal-title":"Clin. Chim. Acta"},{"key":"BF03005702_CR31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/WNL.19.10.993","volume":"19","author":"A.L. Sherwin","year":"1969","unstructured":"Sherwin, A.L., Norris, J.W., &Bulcke, J.A. Spinal fluid creatine kinase in neurologic disease. Neurology19: 993 (1969).","journal-title":"Neurology"},{"key":"BF03005702_CR32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archpsyc.1969.01740190104015","volume":"21","author":"H. Meltzer","year":"1969","unstructured":"Meltzer, H. Muscle enzyme release in the acute psychoses. Arch. Gen. Psychiat.21: 102 (1969).","journal-title":"Arch. Gen. Psychiat."},{"key":"BF03005702_CR33","first-page":"329","volume":"10","author":"A. Nygren","year":"1965","unstructured":"Nygren, A. Muscular involvement in acutely intoxicated alcoholics revealed by elevated serum CPK activity. Opusc. Med. Bd.10: 329 (1965).","journal-title":"Opusc. Med. Bd."},{"key":"BF03005702_CR34","first-page":"857","volume":"64","author":"G.A. Fleisher","year":"1964","unstructured":"Fleisher, G.A. &McConahey, W.M. Serum creatine kinase, lactic dehydrogenase, and glutamic-oxalacetic transaminase in thyroid diseases and pregnancy. J. Lab. Clin. Med.64:857(1964).","journal-title":"J. Lab. Clin. Med."},{"key":"BF03005702_CR35","first-page":"57","volume":"12","author":"F.A. Graig","year":"1963","unstructured":"Graig, F.A. &Ross, G. Serum creatine phosphokinase in thyroid disease. Metabolism12: 57(1963).","journal-title":"Metabolism"},{"key":"BF03005702_CR36","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/0006-2952(71)90455-2","volume":"20","author":"H.Y. Meltzer","year":"1971","unstructured":"Meltzer, H.Y. &Margulies, P. Release of creatine phosphokinase from muscle. I. Effect of polymysin B, compound 48\/80, and serotonin. Biochem. Pharmacol.20: 3501 (1971).","journal-title":"Biochem. Pharmacol."},{"key":"BF03005702_CR37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bja\/45.2.185","volume":"45","author":"R.K.R. Innes","year":"1973","unstructured":"Innes, R.K.R. &Stromme, J.H. Rise in serum creatine phosphokinase associated with agents used in anaesthesia. Brit. J. Anaesth.45: 185 (1973).","journal-title":"Brit. J. Anaesth."},{"key":"BF03005702_CR38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/bja\/38.7.510","volume":"38","author":"T. Tammisto","year":"1966","unstructured":"Tammisto, T. &Airaksinen, M. Increase of creatine kinase activity in serum as sign of muscular injury caused by intermittently administered suxamethonium during halothane anaesthesia. Brit. J. Anaesth. 38: 510 (1966).","journal-title":"Brit. J. Anaesth."},{"key":"BF03005702_CR39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-3476(70)80044-0","volume":"77","author":"R.R. Wolfe","year":"1970","unstructured":"Wolfe, R.R., Ruttenberg, H.D., &Moss, A.J. Serum creatine phosphokinase levels in children undergoing cardiac catheterization. J. Pediat.77: 52 (1970).","journal-title":"J. Pediat."},{"key":"BF03005702_CR40","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(70)91214-6","volume":"ii","author":"M.A. Denborough","year":"1970","unstructured":"Denborough, M.A., Hudson, M.C, Forster, J.F.A., Carter, N.G., &Zapf, P. Biochemical changes in malignant hyperpyrexia. Lancetii: 1137 (1970).","journal-title":"Lancet"},{"key":"BF03005702_CR41","volume-title":"Malignant hyperpyrexia - a serious, preventable complication of general anaesthesia","author":"M.A Denborough","year":"1970","unstructured":"Denborough, M.A, Forster, J.F.A., Hudson, M.C, Carter, N.G., &Zapf, P. Malignant hyperpyrexia - a serious, preventable complication of general anaesthesia. Australasian Congress of Anaesthesiology, Melbourne, Australia (1970)."},{"key":"BF03005702_CR42","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/bja\/42.12.1077","volume":"42","author":"H. Isaacs","year":"1970","unstructured":"Isaacs, H. &Barlow, M.B. The genetic background to malignant hyperpyrexia revealed by serum creatine phosphokinase estimations in asymptomatic relatives. Brit. J. Anaesth.42: 1078 (1970).","journal-title":"Brit. J. Anaesth."},{"key":"BF03005702_CR43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.36.2.228","volume":"36","author":"H. Isaacs","year":"1973","unstructured":"Isaacs, H. &Barlow, M.B. Malignant hyperpyrexia - further muscle studies in asymptomatic carriers identified by creatine phosphokinase screening. J. Neurol. Neurosurg. Psychiat.36: 228 (1973).","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"BF03005702_CR44","first-page":"640","volume":"48","author":"H. Isaacs","year":"1974","unstructured":"Isaacs, H. &Barlow, M.B. Central core disease associated with elevated creatine phosphokinase levels - two members of a family known to be susceptible to malignant hyperpyrexia. South African Med. J.48: 640 (1974).","journal-title":"South African Med. J."},{"key":"BF03005702_CR45","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/bja\/45.8.901","volume":"45","author":"H. Isaacs","year":"1973","unstructured":"Isaacs, H. &Barlow, M.B. Malignant hyperpyrexia occurring in a second Johannesburg family. Brit. J. Anaesth.45: 901 (1973).","journal-title":"Brit. J. Anaesth."},{"key":"BF03005702_CR46","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.1971.03180220047008","volume":"215","author":"J.A. Aldrete","year":"1971","unstructured":"Aldrete, J.A., Padfield, A., Solomons, C.C., &Rebricht, M.W. Possible predictive tests for malignant hyperthermia during anaesthesia. J.A.M.A.215: 1465 (1971).","journal-title":"J.A.M.A."},{"key":"BF03005702_CR47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bmj.2.5913.245","volume":"2","author":"R.F.W. Moulds","year":"1974","unstructured":"Moulds, R.F.W. &Denborough, M.A. Biochemical basis of malignant hyperpyrexia. Brit. Med. J.2: 245 (1974).","journal-title":"Brit. Med. J."},{"key":"BF03005702_CR48","first-page":"220","volume":"51","author":"E.K. Zsigmond","year":"1972","unstructured":"Zsigmond, E.K., Starkweather, W.H., Duboff, G.S., &Flynn, K. CPK and malignant hyperthermia. Anesth. Analg.51: 220 (1972).","journal-title":"Anesth. Analg."},{"key":"BF03005702_CR49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/00359157730661P131","volume":"66","author":"K. Kyei-Mensah","year":"1973","unstructured":"Kyei-Mensah, K., Tyrrell, J.H., &Sumner, D.W. Clinical and genetic aspects of malignant hyperpyrexia. Proc. Roy. Soc. Med.66: 63 (1973).","journal-title":"Proc. Roy. Soc. Med."},{"key":"BF03005702_CR50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/bja\/44.1.93","volume":"44","author":"D.G. Larard","year":"1972","unstructured":"Larard, D.G., Rice, C.P., Robinson, R., Spencer, W., &Westhead, R.A. Malignant hyperthermia: a study of an affected family. Brit. J. Anaesth.44: 93 (1972).","journal-title":"Brit. J. Anaesth."},{"key":"BF03005702_CR51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2044.1973.tb00306.x","volume":"28","author":"J.R. Wedley","year":"1973","unstructured":"Wedley, J.R. &Jaffe, E.C. Malignant hyperpyrexia and the dental outpatient. Anaesthesia28: 146(1973).","journal-title":"Anaesthesia"},{"key":"BF03005702_CR52","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/bmj.3.5826.559","volume":"3","author":"F.R. Ellis","year":"1972","unstructured":"Ellis, F.R., Keaney, N.P., Harriman, D.G.F., Sumner, D.W., Kyei-Mensah, K., Tyrrell, J.H., Hargreaves, J.B., Parikh, R.K., &Mulrooney, P.L. Screening for malignant hyperpyrexia. Brit. Med. J.3: 559 (1972).","journal-title":"Brit. Med. J."},{"key":"BF03005702_CR53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/00359157730661P132","volume":"66","author":"F.R. Ellis","year":"1973","unstructured":"Ellis, F.R., Keaney, N.P., &Harriman, D.G.F. Histopathological and neuropharmacological aspects of malignant hyperpyrexia. Proc. Roy. Soc. Med.66: 66 (1973).","journal-title":"Proc. Roy. Soc. Med."},{"key":"BF03005702_CR54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bmj.2.5913.245","volume":"2","author":"R.F.W. Moulds","year":"1974","unstructured":"Moulds, R.F.W. &Denborough, M.A. Identification of susceptibility to malignant hyperpyrexia. Brit. Med. J.2: 245 (1974).","journal-title":"Brit. Med. J."},{"key":"BF03005702_CR55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1399-6576.1974.tb00700.x","volume":"18","author":"J. Kelstrup","year":"1974","unstructured":"Kelstrup, J., Reske-Nielsen, E., Haase, J., &Jorni, J. Malignant hyperthermia in a family: a clinical and serological investigation of 139 members. Acta anaesth. scand.18: 58 (1974).","journal-title":"Acta anaesth. scand."},{"key":"BF03005702_CR56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(72)92854-1","volume":"1","author":"J.O. King","year":"1972","unstructured":"King, J.O., Denborough, M.A., &Zapf, P. Inheritance of malignant hyperpyrexia. Lancet1: 365 (1972).","journal-title":"Lancet"},{"key":"BF03005702_CR57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-8981(69)90017-5","volume":"23","author":"W.H.S. Thomson","year":"1969","unstructured":"Thomson, W.H.S. An investigation of physical factors influencing the behaviour invitro of serum creatine phosphokinase and other enzymes. Clin. Chim. Acta23: 105 (1969).","journal-title":"Clin. Chim. Acta"},{"key":"BF03005702_CR58","first-page":"696","volume":"69","author":"S.B. Rosalki","year":"1967","unstructured":"Rosalki, S.B. An improved procedure for serum creatine and phosphokinase determination. J. Lab. Clin. Med.69: 696 (1967).","journal-title":"J. Lab. Clin. Med."},{"key":"BF03005702_CR59","unstructured":"Calbiochem CPK Reagents. Document No. LO3012, 1974."},{"key":"BF03005702_CR60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/clinchem\/12.2.95","volume":"12","author":"S. Morgenstern","year":"1966","unstructured":"Morgenstern, S., Oklander, M., Auerbach, J., Kaufman, J., &Klein, B. Automated determination of serum glutamic oxaloacetic transaminase. Clin. Chem.12: 95 (1966).","journal-title":"Clin. Chem."},{"key":"BF03005702_CR61","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3181\/00379727-90-21985","volume":"90","author":"F. Wroblewski","year":"1955","unstructured":"Wroblewski, F. &LaDue, J.S. Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med.90:210(1955).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BF03005702_CR62","doi-asserted-by":"crossref","unstructured":"Kalow, W., Britt, B.A., & Richter, A. The caffeine test of isolated human muscle in relation to malignant hyperthermia. Human Genetics, in press 1976.","DOI":"10.1007\/BF03006711"}],"container-title":["Canadian Anaesthetists\u2019 Society Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03005702.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03005702\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03005702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T03:21:02Z","timestamp":1738812062000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03005702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1976,5]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1976,5]]}},"alternative-id":["BF03005702"],"URL":"https:\/\/doi.org\/10.1007\/bf03005702","relation":{},"ISSN":["0008-2856","1496-8975"],"issn-type":[{"value":"0008-2856","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[1976,5]]}}}